Merck expands manufacturing for molnupiravir. But questions remain.

October 28, 2021 |
In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill
Global health experts weigh-in on putting the pandemic behind us
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...